Alexander W. Teass, Ph.D., Raymond E. Biagini, Ph.D., D. Gayle DeBord, Ph.D., NIOSH/DBBS, and R. DeLon Hull, Ph.D., NIOSH/DSHEFS, Chapter F (1994)
“ Biological monitoring of exposure. A biomarker of exposure represents uptake of the agent through all routes of exposure. Thus, compared to air monitoring, biological monitoring offers a better estimate of the health risk in situations where routes of exposure other than inhalation are significant. ”
